Where are the new treatments?
The current economic downtrend and all the deserved and undeserved criticisms of the drug companies seem to have slowed down the pace of new therapies dramatically. The high cost of research as well as the development of a subtle bias against medications and biological therapies seem to be discouraging innovation and pioneering work. We see a lot of repackaging and slow-release preparation of old treatments with brand name costs.
What is needed is support of research centers that does not come from industry, and a concerted effort not to relinquish our quest to find better prevention and treatment for these devastating conditions. I do hope the break-through revolution in the treatment of these brain illnesses is not stillborn!
Tags: therapies; new